BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization

AI-based biopharma commercialization company BranchLab recently announced the completion of a $26 million Series-A funding round, led by McKesson Ventures and with additional participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures, bringing the company's total funding to $35 million. With this new capital, BranchLab will expand upon and scale its AI-platform Pathwai™ to continue helping to replace "fragmented, offline workflows with a unified, privacy-first AI platform-driving a nearly 70% increase in commercialization efficacy" for pharma teams and their partners.

McKesson Ventures Partner Carrie Williams expressed her excitement about this announcement, saying "The more we learned about BranchLab, the more we saw the possibility to transform the way patients learn about and get started on the right therapies. Combining a deep understanding of the patient journey with a future-proofed approach to patient activation could enable an evolved patient therapy experience, one that seamlessly bridges privacy-first audience targeting with patient access, affordability and preference."

BranchLab CEO and co-founder Josh Walsh provided some additional context for the company's mission in the press release, stating "Pharma has long had access to rich data, but using it quickly-and responsibly-has been the challenge. BranchLab solves this by turning privacy-safe, aggregated data into real-time insights that connect directly to activation. Teams can move faster, reach the right audiences more effectively, and drive better outcomes without relying on sensitive or individual-level information."

Founded in 2024 by Josh Walsh, Michael Parkes, and Chris Cagle, BranchLab has quickly made a name for itself by developing the Pathwai™ AI-platform for healthcare commercialization that's privacy-safe, rigorous, and designed for real-world use. The company currently works with a number of brands across the pharmaceutical, healthcare, government, and retail sectors, and has offices based out of New York, Colorado, and San Francisco. For more information about this announcement, read the BranchLab press release below.

See related materials:

• BranchLab press release
• BranchLab website
• BranchLab LinkedIn
• Carrie Williams LinkedIn
• Josh Walsh LinkedIn